Chief Financial Officer · Traws Pharma, Inc. · Traws Pharma, Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
61.6K
Price
—
Executed
Dec 12, 2025
Disclosed
Apr 8, 2026
Disclosure timeline117 days from execution to publication · legal deadline 2 business days
Dec 12 executedApr 8, 2026 disclosed
TRAW · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+15 / 15
Disclosed 83 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Parker Charles Nolan filed this Form 4 reporting a grant or award of TRAW on Dec 12, 2025. It became public on Apr 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Parker Charles Nolancik:0002125562
Issuer
Traws Pharma, Inc.cik:0001130598
Revision history · 0
No field has changed since this record was first ingested.
